Latest From Scrip Team
Pipeline Watch: 23 Approvals And 14 Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Arvinas Nabs New Chief Financial Officer From Intercept Pharmaceuticals
Recent moves in the industry include changes at the top for Sumitomo Pharma, ASKA and Takeda, plus Maat Pharma gets a new chief medical officer.
Pipeline Watch: 12 Approvals And 18 Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: New Hires At Eisai, Connect Biopharma, Actylis And More
Recent moves in the industry include new chief executive officers at Connect Biopharma, Skyhawk Therapeutics and Actylis, plus I-Mab gets new chief medical officer.
Pipeline Watch: 8 Approvals and 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Three New CFOs And One New CEO Among This Week's Changes
Recent moves in the industry include C-suite shuffles at MorphoSys, Centessa Pharmaceuticals and Skyhawk Therapeutics, plus bluebird bio acquires a new chief financial officer.